GlassScriptPhysician profile
Anthony T Sonn
NPI 1265489561
$79,930.81
in general payments reported to CMS, 2019-2025
31 companies · $48K in 2025
The $48K reported for 2025 was more than what 97% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,670 · 2020: $478 · 2021: $17K · 2022: $3,045 · 2023: $5,450 · 2024: $4,277 · 2025: $48K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $35K · Travel and Lodging: $14K · Food and Beverage: $7,980 · Consulting Fee: $530 · Education: $17.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $35,300.00 |
| Travel and Lodging | $14,023.32 |
| Food and Beverage | $7,979.65 |
| Consulting Fee | $530.00 |
| Education | $17.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $72,014.72 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Boston Scientific Corporation | $2,590.39 | 2019-2025 | General - Vascular Access, Avvigo Guidance System, Intellanav Mifi Xp |
| Abbott Laboratories | $1,265.13 | 2019-2025 | Amplatzer Amulet, Ensite, Mitraclip |
| Abiomed | $1,035.49 | 2019-2025 | Impella |
| Medtronic, INC. | $641.73 | 2021-2024 | Corevalve Evolut R, Linq II, Ffrangio |
| Inari Medical, INC. | $348.34 | 2021-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| E.R. Squibb & Sons, L.L.C. | $305.05 | 2022-2025 | Camzyos, Eliquis |
| Amgen INC. | $230.71 | 2019-2025 | Repatha, Repatha |
| Cvrx, INC. | $192.42 | 2022-2024 | Barostim Neo System |
| Pfizer INC. | $165.11 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $161.14 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $135.08 | 2020-2022 | |
| Biosense Webster, INC. | $99.88 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $97.75 | 2022-2025 | Lifevest |
| Medtronic Vascular, INC. | $69.84 | 2019 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $64.22 | 2021 | |
| Biotronik INC. | $62.26 | 2021-2022 | |
| Lsi Solutions INC | $57.69 | 2019 | |
| Cardiva Medical, INC. | $54.04 | 2021-2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f, Cardiva Vascade Mvp Vvcs 6-12f |
| Boehringer Ingelheim Pharmaceuticals, INC. | $50.19 | 2023-2024 | Jardiance |
| Kiniksa Pharmaceuticals, LTD. | $43.17 | 2023 | Arcalyst |
| Heartflow, INC. | $43.07 | 2025 | |
| Janssen Pharmaceuticals, INC | $39.47 | 2022 | |
| Philips North America LLC | $37.71 | 2024 | (Ao0) Igt Devices Intracardiac |
| Esperion Therapeutics, INC. | $25.80 | 2024 | Nexletol |
| Siemens Medical Solutions USA, INC. | $25.71 | 2024 | Acuson Origin Diagnostic Ultrasound System |
| Kestra Medical Technology Services, INC. | $18.97 | 2025 | Assure Wcd |
| Bridgebio Pharma, INC. | $17.57 | 2025 | Attruby |
| Bayer Healthcare Pharmaceuticals INC. | $14.19 | 2025 | |
| Baylis Medical Company INC | $12.73 | 2021 | |
| Getinge USA Sales, LLC | $11.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Sonn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.